Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 8;15(1):11.
doi: 10.1186/s13071-021-05130-5.

Characterization of Anopheles gambiae D7 salivary proteins as markers of human-mosquito bite contact

Affiliations

Characterization of Anopheles gambiae D7 salivary proteins as markers of human-mosquito bite contact

Brenda Oseno et al. Parasit Vectors. .

Abstract

Background: Malaria is transmitted when infected Anopheles mosquitoes take a blood meal. During this process, the mosquitoes inject a cocktail of bioactive proteins that elicit antibody responses in humans and could be used as biomarkers of exposure to mosquito bites. This study evaluated the utility of IgG responses to members of the Anopheles gambiae D7 protein family as serological markers of human-vector contact.

Methods: The D7L2, D7r1, D7r2, D7r3, D7r4 and SG6 salivary proteins from An. gambiae were expressed as recombinant antigens in Escherichia coli. Antibody responses to the salivary proteins were compared in Europeans with no prior exposure to malaria and lifelong residents of Junju in Kenya and Kitgum in Uganda where the intensity of malaria transmission is moderate and high, respectively. In addition, to evaluate the feasibility of using anti-D7 IgG responses as a tool to evaluate the impact of vector control interventions, we compared responses between individuals using insecticide-treated bednets to those who did not in Junju, Kenya where bednet data were available.

Results: We show that both the long and short forms of the D7 salivary gland antigens elicit a strong antibody response in humans. IgG responses against the D7 antigens reflected the transmission intensities of the three study areas, with the highest to lowest responses observed in Kitgum (northern Uganda), Junju (Kenya) and malaria-naïve Europeans, respectively. Specifically, the long form D7L2 induced an IgG antibody response that increased with age and that was lower in individuals who slept under a bednet, indicating its potential as a serological tool for estimating human-vector contact and monitoring the effectiveness of vector control interventions.

Conclusions: This study reveals that D7L2 salivary antigen has great potential as a biomarker of exposure to mosquito bites and as a tool for assessing the efficacy of vector control strategies such as bednet use.

Keywords: Anopheles gambiae; Biomarker of exposure; Infectious bites; Malaria; Plasmodium falciparum.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
SDS-PAGE image of the recombinant mosquito salivary antigens
Fig. 2
Fig. 2
IgG responses to gSG6 and D7 salivary antigens. Plasma IgG levels to D7 proteins were compared between malaria-naïve European adults (n = 35), a cohort of children from Junju in Kilifi (n = 313) and a cohort Kitgum in northern Uganda (n = 147). The P-value was determined by the Kruskal–Wallis test (***P < 0.001)
Fig. 3
Fig. 3
IgG responses to gSG6 and D7 salivary antigens stratified by age among individuals resident in Kilifi, Kenya (0–3 years [n = 62], 3–6 years [n = 85], > 7 years [n = 166]). The P-values were determined by the Kruskal–Wallis test (ns, not significant; **P < 0.01; *P < 0.05)
Fig. 4
Fig. 4
IgG responses to recombinant D7L2 compared between individuals who used insecticide-treated bednets (n = 158) and those who did not (n = 155). The P-value was determined by the Wilcoxon rank-sum test (ns, not significant; ** P < 0.01)

References

    1. Titus RG, Bishop JV, Mejia JS. The immunomodulatory factors of arthropod saliva and the potential for these factors to serve as vaccine targets to prevent pathogen transmission. Parasite Immunol. 2006;28:131–141. - PubMed
    1. Remoue F, Cisse B, Ba F, Sokhna C, Herve JP, Boulanger D, et al. Evaluation of the antibody response to Anopheles salivary antigens as a potential marker of risk of malaria. Trans R Soc Trop. 2006;100:363–370. doi: 10.1016/j.trstmh.2005.06.032. - DOI - PubMed
    1. Drame PM, Poinsignon A, Besnard P, Le Mire J, Dos-Santos MA, Sow CS, et al. Human antibody response to Anopheles gambiae Anopheles gambiae saliva: An immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control. Am J Trop Med Hyg. 2010;83:115–121. doi: 10.4269/ajtmh.2010.09-0684. - DOI - PMC - PubMed
    1. Ali ZMI, Bakli M, Fontaine A, Bakkali N, Hai VV, Audebert S, et al. Assessment of Anopheles salivary antigens as individual exposure biomarkers to species-specific malaria vector bites. Malar J. 2012 doi: 10.1186/1475-2875-11-439. - DOI - PMC - PubMed
    1. Poinsignon A, Cornelie S, Mestres-Simon M, Lanfrancotti A, Rossignol M, Boulanger D, et al. Novel peptide marker corresponding to salivary protein gSG6 potentially identifies exposure to Anopheles bites. PLoS ONE. 2008;3:e2472. doi: 10.1371/journal.pone.0002472. - DOI - PMC - PubMed

MeSH terms